009300 — Sam-A Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual cashflow statement for Sam-A Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	124	3,392	11,912	21,374	22,080
Depreciation
Amortisation
Non-Cash Items	3,992	2,833	6,516	2,279	2,669
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,401	3,019	-2,010	-6,788	-3,767
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	9,408	12,943	19,604	20,760	25,247
Capital Expenditures	-680	-275	-239	-3,820	-6,512
Purchase of Fixed Assets
Other Investing Cash Flow Items	482	-19,521	-12,793	-16,987	-14,899
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-198	-19,796	-13,032	-20,807	-21,411
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,665	-3,670	-5,381	-112	-3,522
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	5,397	-10,411	1,191	-156	532